HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Engineering an anti-Stx2 antibody to control severe infections of EHEC O157:H7.

Abstract
Enterohaemorrhagic Escherichia coli (EHEC) O157:H7, a primary enteric pathogen, has been implicated in a wide spectrum of food/water-borne infectious diseases such as hemorrhagic colitis (HC) and hemolyticuremic syndrome (HUS). Effective treatments for EHEC O157:H7 induced disease are not available yet. Shiga-toxin 2 (Stx2) has been related to clinical manifestations of HUS, suggesting its critical role in pathology following infection with EHEC O157:H7. Here we report the development of four anti-Stx2-Monoclonal antibodies (McAbs) (5F3and 5C11 for Stx2A, and 1A4 and 1A5 for Stx2B), all of which have strong immunogenicity and neutralization activities in vitro and in vivo. The full-length cDNA coding for anti-Stx2A McAb, 5F3, was cloned and an engineered antibody was developed whose therapeutic effects were evaluated. Our data indicate that the engineered scFv together with two new McAbs may be applicable for the prevention and therapy of EHEC induced pathology.
AuthorsYing Ma, Xuhu Mao, Jun Li, Haixia Li, Youjun Feng, Hongzhang Chen, Ping Luo, Jiang Gu, Shu Yu, Hao Zeng, Gang Guo, Kang Yang, Quanming Zou
JournalImmunology letters (Immunol Lett) Vol. 121 Issue 2 Pg. 110-5 (Dec 22 2008) ISSN: 1879-0542 [Electronic] Netherlands
PMID19007817 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Immunoglobulin Variable Region
  • Recombinant Fusion Proteins
  • Shiga Toxin 2
Topics
  • Animals
  • Antibodies, Monoclonal (genetics, immunology, metabolism, therapeutic use)
  • B-Lymphocytes (immunology, metabolism, pathology)
  • Escherichia coli Infections (complications, immunology, therapy)
  • Escherichia coli O157 (immunology, pathogenicity)
  • Genetic Engineering
  • Hemolytic-Uremic Syndrome (etiology, prevention & control)
  • Humans
  • Hybridomas
  • Immunization, Passive (trends)
  • Immunoglobulin Variable Region (genetics, immunology, metabolism, therapeutic use)
  • Mice
  • Protein Conformation
  • Recombinant Fusion Proteins (genetics, immunology, metabolism, therapeutic use)
  • Shiga Toxin 2 (genetics, immunology)
  • Species Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: